Selective Labeling and Identification of the Tumor Cell Proteome of Pancreatic Cancer In Vivo | Journal of Proteome Research
Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology
Identification and prognostic analysis of biomarkers to predict the progression of pancreatic cancer patients | Molecular Medicine | Full Text
Trends in Neoadjuvant Approaches in Pancreatic Cancer in: Journal of the National Comprehensive Cancer Network Volume 15 Issue 8 (2017)
Consensus guidelines for diagnosis, treatment and follow-up of patients with pancreatic cancer in Spain | SpringerLink
Moving the Bar in Pancreatic Cancer
Treatment for potentially resectable exocrine pancreatic cancer - UpToDate
Circulating stromal cells in resectable pancreatic cancer correlates to pathological stage and predicts for poor clinical outcomes | npj Precision Oncology
Frontiers | Predictive Biomarkers for a Personalized Approach in Resectable Pancreatic Cancer
What Makes a Pancreatic Cancer Resectable? | American Society of Clinical Oncology Educational Book
Identification and prognostic analysis of biomarkers to predict the progression of pancreatic cancer patients | Molecular Medicine | Full Text
Markers of pancreatic cancer stem cells and their clinical and therapeutic implications | SpringerLink
Definition and Management of Borderline Resectable Pancreatic Cancer
Frontiers | CA19.9 Serum Level Predicts Lymph-Nodes Status in Resectable Pancreatic Ductal Adenocarcinoma: A Retrospective Single-Center Analysis
Pancreatic Cancer CT: Prediction of Resectability according to NCCN Criteria | Radiology
New Treatment Options and Management Considerations in Borderline Resectable Pancreatic Cancer
Markers of pancreatic cancer stem cells and their clinical and therapeutic implications | SpringerLink
Identification and prognostic analysis of biomarkers to predict the progression of pancreatic cancer patients | Molecular Medicine | Full Text
Pancreatic Cancer Tumor Markers | GeneTex
Circulating stromal cells in resectable pancreatic cancer correlates to pathological stage and predicts for poor clinical outcomes | npj Precision Oncology
Identification and prognostic analysis of biomarkers to predict the progression of pancreatic cancer patients | Molecular Medicine | Full Text
Circulating tumor DNA as a prognostic indicator in resectable pancreatic ductal adenocarcinoma: A systematic review and meta-analysis | Scientific Reports
Frontiers | Predictive Biomarkers for a Personalized Approach in Resectable Pancreatic Cancer
Pancreatic Cancer—the Current Landscape - touchONCOLOGY